(Q52169190)

26 April 2018

title

The NMDA antagonist EAA 494 does not impair working memory in an operant DNMTP task in rats. (English)

1 reference

26 April 2018

author name string

T M Ballard

series ordinal

1

1 reference

26 April 2018

K H Mcallister

series ordinal

2

1 reference

26 April 2018

language of work or name

English

0 references

publication date

1 April 2000

1 reference

26 April 2018

Pharmacology, Biochemistry and Behavior

published in

1 reference

26 April 2018

volume

65

1 reference

26 April 2018

issue

4

1 reference

26 April 2018

page(s)

725-730

1 reference

26 April 2018

The acetylcholinesterase inhibitor, ENA 713 (Exelon), attenuates the working memory impairment induced by scopolamine in an operant DNMTP task in rats.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900255-5

7 January 2021

A synaptic model of memory: long-term potentiation in the hippocampus

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900255-5

7 January 2021

Contrasting effects of the competitive NMDA antagonist CPP and the non-competitive NMDA antagonist MK 801 on performance of an operant delayed matching to position task in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900255-5

7 January 2021

Learning impairment in rats by N-methyl-D-aspartate receptor antagonists.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900255-5

7 January 2021

A comparison of the effects of the novel muscarinic receptor agonists L-689,660 and AF102B in tests of reference and working memory.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900255-5

7 January 2021

Comparative effects of cholinergic drugs and lesions of nucleus basalis or fimbria-fornix on delayed matching in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900255-5

7 January 2021

Effects of infusion of cholinergic drugs into the prefrontal cortex area on delayed matching to position performance in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900255-5

7 January 2021

The pharmacology of SDZ EAA 494, a competitive NMDA antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900255-5

7 January 2021

The competitive NMDA receptor antagonist SDZ 220-581 reverses haloperidol-induced catalepsy in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900255-5

7 January 2021

Selective impairment of learning and blockade of long-term potentiation by an N-methyl-D-aspartate receptor antagonist, AP5

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900255-5

7 January 2021

Effects of the novel NMDA-receptor antagonist SDZ EAA 494 on memory and attention in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900255-5

7 January 2021

Dissociation between cognitive and motor/motivational deficits in the delayed matching to position test: effects of scopolamine, 8-OH-DPAT and EAA antagonists.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900255-5

7 January 2021

AMPA antagonists differ from NMDA antagonists in their effects on operant DRL and delayed matching to position tasks.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900255-5

7 January 2021

Effects of the NMDA antagonists CPP and MK-801 on delayed conditional discrimination.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900255-5

7 January 2021

The competitive NMDA antagonist AP5, but not the non-competitive antagonist MK801, induces a delay-related impairment in spatial working memory in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900255-5

7 January 2021

Effects of the NMDA antagonists CPP and MK-801 on radial arm maze performance in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900255-5

7 January 2021

N-methyl-D-aspartate antagonists and working memory performance: Comparison with the effects of scopolamine, propranolol, diazepam, and phenylisopropyladenosine

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900255-5

7 January 2021

10.1016/S0091-3057(99)00255-5

Identifiers

DOI

1 reference

26 April 2018

1 reference

26 April 2018